We believe Africa
will revolutionize the
global genomics market"

About Us

54gene is an African genomics company building the world’s largest pan-African biobank. The company was founded in 2019 by Dr. Abasi Ene-Obong to unlock the African genome and improve our understanding of the world’s most genetically diverse population.

54gene is partnering with hospitals and research institutions in African countries; and with pharmaceutical and biotechnology companies to address the challenge of limited diverse genomics data, which may hold the key to medical discoveries and new healthcare solutions.

Backed by investors including Y Combinator, Fifty Years Ventures, Better Ventures, and KdT Ventures, 54gene aims to equilibrate healthcare for people of African origin while advancing the quality of medical care worldwide.

Our Investors

Meet Our Team

Abasi Ene-Obong PhD

Chief Executive Officer

Delali Attipoe

Chief Operations Officer

Jessica Rich

Chief Commercial Officer

Abi Galadima

Chief of Staff

Francis Osifo

VP of Engineering & Head of Technology, Africa

Estelle Dogbo

VP of Diagnostics & Country Head, Nigeria

Dr. Zara Modibbo

VP Laboratory OperationsHead of Clinical Laboratory Services, Africa

Aminu Yakubu

VP Research Planning & Ethics

Dr. Jumi Popoola

Director of Scientific Services, Africa

Dr. Nabila Ado Wanka

Head of Histopathology

Yemisi Osakwe

Director of Provider Engagement

Ijeoma Onuoha

Director, Ecosystem Partnerships, Africa

Excited about building
Africa’s fastest growing
genomics company?
Join us.

View open positions

Join Us On Our Journey